Kewaunee Scientific (NASDAQ:KEQU) Upgraded at StockNews.com

StockNews.com upgraded shares of Kewaunee Scientific (NASDAQ:KEQU) from a hold rating to a buy rating in a research note issued to investors on Wednesday morning.

Kewaunee Scientific Stock Performance

Kewaunee Scientific stock opened at $53.87 on Wednesday. The business has a 50 day moving average of $39.78 and a 200-day moving average of $42.57. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.53 and a quick ratio of 2.00. Kewaunee Scientific has a 1 year low of $24.67 and a 1 year high of $56.95. The company has a market capitalization of $154.71 million, a P/E ratio of 8.54 and a beta of 0.80.

Insider Transactions at Kewaunee Scientific

In other news, VP Elizabeth D. Phillips sold 1,850 shares of the firm’s stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $54.17, for a total transaction of $100,214.50. Following the completion of the transaction, the vice president now directly owns 13,591 shares in the company, valued at $736,224.47. This trade represents a 11.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 14.20% of the stock is owned by company insiders.

Institutional Trading of Kewaunee Scientific

A number of institutional investors and hedge funds have recently added to or reduced their stakes in KEQU. Dimensional Fund Advisors LP lifted its position in shares of Kewaunee Scientific by 3.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock worth $8,378,000 after purchasing an additional 6,132 shares during the period. Renaissance Technologies LLC boosted its position in Kewaunee Scientific by 13.4% during the second quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock valued at $4,230,000 after acquiring an additional 10,580 shares during the last quarter. De Lisle Partners LLP grew its holdings in Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after acquiring an additional 11,511 shares during the period. Geode Capital Management LLC grew its holdings in Kewaunee Scientific by 8.9% during the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after acquiring an additional 1,941 shares during the period. Finally, Ritholtz Wealth Management grew its holdings in Kewaunee Scientific by 24.6% during the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock worth $363,000 after acquiring an additional 2,156 shares during the period. Institutional investors and hedge funds own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.